NJ Bio is thrilled to be a Senior Partner and Sponsor at the 13th World ADC Conference to be held in San Diego, California on September 6-9, 2022. The World ADC Conference is the most comprehensive and longest standing Antibody-Drug Conjugate Conference that provides insights into the latest development in the ADC field. This conference will shed light on combination ADCS, next generation payloads, use of biomarkers in clinical development, as well as how to evolve manufacturing process to mitigate supply challenges.
Over the years, NJ Bio has stayed committed to the ADC field by sponsoring events and has been dedicated to educating the community. This year as well, NJ Bio is a senior partner and sponsor at the World ADC conference and Naresh Jain, President, and CEO of NJ Bio is conducting a workshop on ADCs and presenting a talk on “Accelerated Pathway from Antibody to ADC”. We look forward to seeing our clients and the attendees who may be new to the ADC world, to network and collaborate with them, and help accelerate their programs!